Unknown

Dataset Information

A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia.


ABSTRACT:

SUBMITTER: Uy GL 

PROVIDER: S-EPMC5380905 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature